Harmony Biosciences Sets CEO Transition, Reiterates 2026 WAKIX Guidance

Peter Anastasiou will become CEO on Jan. 1, 2027, as Jeffrey M. Dayno retires Dec. 31, 2026. The company reiterated 2026 WAKIX net revenue guidance of $1.0 billion to $1.04 billion and expects BP-205 MAD data in Q4 2026.